In the present study, we demonstrated that patients with mutant lung adenocarcinoma with high D-dimer levels in their peripheral blood were less responsive to EGFR TKI, were more vulnerable to develop early disease progression, and had shorter survival. This evidence concerns the gene EGFR and lung adenocarcinoma.